Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Syneos Health
Efforts to improve trial diversity predate COVID-19, but the pandemic’s disproportionate effects on minority communities have brought the issue to the forefront.
Newly public Aligos will team with Merck & Co. on oligonucleotide therapies for NASH. Maze Therapeutics launches ophthalmology and CV-focused spinouts with Alloy and BridgeBio.
- Contract Research Organization-CRO
- Medical Devices
- Other Names / Subsidiaries